The Palmer Foundation takes on challenge to source a COVID-19 treatment

Our world has been turned upside down. We have the daunting prospect of thousands, or even millions of people being affected by COVID-19. A lot of people have talked about a vaccine, and while a vaccine (which prevents you getting a disease) is vitally important, we have to look at what we can do when people do get the disease.

The malaria drug hydroxychloroquine is showing enormous promise in the treatment of COVID-19. That’s why The Palmer Foundation is making resources available to fund clinical trials, scale up the availability of hydroxychloroquine as soon as we can, and have enough of the drug available for all Australians, free of charge.

The initial aim was to acquire 30 million doses, but the bigger picture goal is to help get underway the ability to manufacture the medicine right here in Australia.

 

It is important for us to see through the chaff out there. We hope you find these resources valuable. This is a situation that changes every day, and affects everyone. When it comes to life and death, politics and profit should not compete with real world solutions that are affordable to all right now.

COVID-19 survivals

12/06/2020
11/06/2020
05/06/2020
05/06/2020
22/05/2020
19/05/2020
16/05/2020
12/05/2020
07/05/2020
02/05/2020
28/04/2020
28/04/2020
23/04/2020
22/04/2020
21/04/2020
17/04/2020
17/04/2020
17/04/2020
15/04/2020
15/04/2020
15/04/2020
10/04/2020
09/04/2020
08/04/2020
08/04/2020
08/04/2020
07/04/2020
07/04/2020
06/04/2020
04/04/2020
03/04/2020
02/04/2020
30/03/2020
17/03/2020

Documentary: Perspectives on the Pandemic | The (Undercover) Epicenter Nurse | Episode Nine

A Patient Story
blank

After 13 ER visits, woman with COVID-19 needed to travel to Dallas for hydroxychloroquine treatments

A Patient Story
blank

COVID-19 Survivor Lonnie Haley: High blood, prediabetic and treated with HCQ

A Patient Story
blank

Firefighter, paramedic and now corona virus survivor Joe Biasi treated with hydroxychloroquine

A Patient Story
blank

Metro Atlanta woman with high blood pressure says hydroxychloroquine helped her overcome COVID-19

A Patient Story
blank

Fact vs. fiction: Hydroxychloroquine works, says another survivor

A Patient Story
blank

Pune: ‘I am 80, but I have defeated coronavirus’

A Patient Story
blank

Bob Knakal Had COVID-19 And Took Hydroxychloroquine To Treat Symptoms

A Patient Story
blank

Enacting ‘Right to Try’ Act for Hydroxychloroquine Saves 99-year-old Little Rock woman from Covid-19

A Patient Story
blank

Jacksonville man treated with HCQ survives COVID-19, donating plasma to help others escape death

A Patient Story
blank

Daniel and Liz Penny had coronavirus. It was awful.

A Patient Story
blank

Doctor sees success in using hydroxychloroquine for COVID-19

A Patient Story
blank

Nurse describes ‘roller coaster’ of symptoms before hydroxychloroquine treatment

A Patient Story
blank

S.I. coronavirus diary: This COVID-19 survivor says hydroxychloroquine helped save his life

A Patient Story
blank

Torrance Doctor Recovers From Coronavirus, Credits Z-Pack/Zinc/Hydroxychloroquine Treatment

A Patient Story
blank

D.C. attorney credits hydroxychloroquine with saving his life

A Patient Story
blank

Elderly woman, 99, on track to recover from coronavirus after taking hydroxychloroquine

A Patient Story
blank

Teen Challenge Co-Founder Given Hydroxychloroquine, Recovers from COVID-19 at 80-Years-Old

A Patient Story
blank

Coronavirus survivors tell U.S. President hydroxychloroquine helped

A Patient Story
blank

Elderly couple survives coronavirus, credit local doctors and hydroxychloroquine

A Patient Story
blank

39 elderly Texans successfully complete hydroxychloroquine treatment for COVID-19, doctor says

A Patient Story
blank

Louisville man says hydroxycholoroquine saved his life.

A Patient Story
blank

‘I was terrified’ Man with laryngeal cancer survives COVID-19, HCQ gave him headaches, but very lucky to have it.

A Patient Story
blank

An E.R. Doctor Infected With Covid-19 Back At Work After Using Hydroxychloroquine and Z-Pak Protocol

A Patient Story
blank

Another hydroxychloroquine success story: Dr. Marc Siegel says hydroxychloroquine cured his 96-year-old father of coronavirus

A Patient Story
blank

Bon Jovi Keyboardist Took Hydroxychloroquine For Coronavirus and Improved

A Patient Story
blank

Michigan Democratic lawmaker Karen Whitsett – ‘hydroxychloroquine saved my life’.

A Patient Story
blank

NYC COVID-19 Survivor Says Drug Hydroxychloroquine Helped Save His Life

A Patient Story
blank

Rich Yanuzzi hunts down hydroxychloroquine for his sick 93 yr old mom, and she survives Covid-19

A Patient Story
blank

Coronavirus News: Woman credits experimental drug hydroxychloroquine for COVID-19 recovery

A Patient Story
blank

COVID-19 – “Hydroxychloroquine saved my life”.

A Patient Story
blank

Oregon veteran celebrates coronavirus recovery on 104th birthday

A Patient Story
blank

Macomb man with COVID-19 says Hydroxychloroquine, Azithromycin saved him

A Patient Story
blank

Manalapan Woman Given Experimental Drugs Including Hydroxychloroquine, Survives Coronavirus

A Patient Story

Research, studies, and clinical trials

02/07/2020
01/07/2020
30/06/2020
29/06/2020
29/06/2020
29/06/2020
26/06/2020
25/06/2020
25/06/2020
22/06/2020
22/06/2020
22/06/2020
22/06/2020
22/06/2020
20/06/2020
20/06/2020
19/06/2020
19/06/2020
17/06/2020
17/06/2020
16/06/2020
16/06/2020
15/06/2020
14/06/2020
12/06/2020
12/06/2020
12/06/2020
12/06/2020
10/06/2020
10/06/2020
08/06/2020
06/06/2020
05/06/2020
04/06/2020
04/06/2020
04/06/2020
03/06/2020
02/06/2020
02/06/2020
01/06/2020
31/05/2020
30/05/2020
30/05/2020
30/05/2020
29/05/2020
28/05/2020
28/05/2020
28/05/2020
28/05/2020
28/05/2020
28/05/2020
28/05/2020
28/05/2020
28/05/2020
26/05/2020
26/05/2020
25/05/2020
24/05/2020
21/05/2020
21/05/2020
21/05/2020
21/05/2020
18/05/2020
18/05/2020
18/05/2020
17/05/2020
15/05/2020
15/05/2020
15/05/2020
12/05/2020
12/05/2020
12/05/2020
09/05/2020
08/05/2020
08/05/2020
08/05/2020
04/05/2020
03/05/2020
02/05/2020
02/05/2020
01/05/2020
30/04/2020
30/04/2020
30/04/2020
29/04/2020
27/04/2020
24/04/2020
22/04/2020
21/04/2020
21/04/2020
21/04/2020
18/04/2020
17/04/2020
17/04/2020
16/04/2020
15/04/2020
14/04/2020
13/04/2020
11/04/2020
11/04/2020
blank

Hydroxychloroquine significantly lowers COVID-19 death rate, Henry Ford Health study finds

Azithromycin
blank

HENRY FORD STUDY: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19

Azithromycin
blank

C19 Study: 48 studies (28 peer reviewed) showing “very positive” results using HCQ as pre & post exposure prophylaxis & early treatment.

Clinical Trials
blank

How a False Hydroxychloroquine Narrative Was Created. “Dangerous” When Used for Covid-19

Clinical Trials
blank

Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection.

Hydroxychloroquine
blank

Electrocardiographic safety of daily Hydroxychloroquine 400mg plus Azithromycin 250mg as an ambulatory treatment for COVID-19 patients in Cameroon.

Azithromycin
blank

National Cancer Instititute: List of Active Clinical Trials Using Hydroxychloroquine for Cancer

Clinical Trials
blank

France Soir: Oxford, Recovery and Solidarity – Overdosage in two clinical trials with acts considered criminal?

Clinical Trials
blank

Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/ azithromycin and other regimens in Marseille, France: A retrospective analysis

France
blank

Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of COVID-19 Spike pseudotype virus

China
blank

Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: a prospective open-label randomized controlled study

China
blank

A new study shows hydroxychloroquine would get out of hospital faster

France
blank

Denmark: Chloroquine, but not hydroxychloroquine, prolongs the QT interval in a primary care population

Chloroquine
blank

Study|China- Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: a prospective open-label randomized controlled study

Chloroquine
blank

Bring on Britain’s corona clowns

Hydroxychloroquine
blank

Brazil: Doctor says Hydroxychloroquine should be initial treatment

Brazil
blank

India: HCQ beneficial as preventive drug: SMS doctors told ICMR

Hydroxychloroquine
blank

Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: a cohort study of 4,642 in-patients in France

Clinical Trials
blank

Researchers Overdosing COVID-19 Patients on Hydroxychloroquine, States Association of American Physicians & Surgeons (AAPS)

Clinical Trials
blank

Hydroxychloroquine is an anchor to prevent COVID-19 ICU Admissions In Malaysia: Expert

Hydroxychloroquine
blank

WHO “Solidarity” and UK “Recovery” Clinical Trials of Hydroxychloroquine Using Potentially Fatal Doses

Clinical Trials
blank

Due to significantly improved outcome, Henry Ford Health System continues hydroxychloroquine study

Hydroxychloroquine
blank

Another anti hydroxychloroquine Study Turns out to Be a Joke

Chloroquine
blank

WHO and UK trials use potentially lethal hydroxychloroquine dose-according to WHO consultant

Canada
blank

A short therapeutic regimen based on hydroxychloroquine plus azithromycin for the treatment of COVID-19 in patients with non-severe disease. A strategy associated with a reduction in hospital admissions and complications.

Azithromycin
blank

Study: Strategy – HCQ + AZ treats mild COVID-19 to reduce hospital admissions and complications.

Hydroxychloroquine
blank

Study: Pre exposure Hydroxychloroquine use reduces COVID19 risk in healthcare workers

Hydroxychloroquine
blank

Indonesia Claims Five Drug Combos, including HCQ, Reduce Novel Coronavirus

Hydroxychloroquine
blank

Surgisphere: mass audit of studies linked to firm behind anti-hydroxychloroquine Lancet study scandal

Global
blank

Decreased mortality and hospital – Doxycycline and Hydroxychloroquine for High-Risk COVID-19 Patients: Case Series of 54 Patients in Long-Term Care

Hydroxychloroquine
blank

Preventive HCQ measures saved city cops from getting infected.

Hydroxychloroquine
blank

Study – Clinical Efficacy of Chloroquine derivatives in COVID-19 Infection: Comparative meta-analysis between the Big data and the real world (19,270 patients – is effective)

France
blank

Lancet RETRACTS suspect research study of 96,000, which stated HCQ had no effect. Important win for science.

Global
blank

WHO restarts Hydroxychloroquine trials globally after dubious study derailed progress – they’ve confirmed no risk of mortality

Clinical Trials
blank

WHO told governments to stop using HCQ based on suspect data from tiny US company. Trials now continue with new confidence.

Australia
blank

WHO restarts HCQ trial after Lancet concern over paper that trashed it

Clinical Trials
blank

WHO resumes hydroxychloroquine study for Covid-19, after confirming no safety concerns from falsified Lancet study

Clinical Trials
blank

HCQ: The Lancet announces serious scientific questions about it’s own published study, which immediately halted WHO trials around the globe

Clinical Trials
blank

Why That Observational Study of Hydroxychloroquine in The Lancet Seems Fishy

Global
blank

80% dip in infection risk for Indian health staff on HCQ: Study

Hydroxychloroquine
blank

Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19

France
blank

LancetGate: Surgisphere – is the company which provided the data to the study serious?

France
blank

Lancet HCQ, A Study Out of Thin Air

Global
blank

The big scam against hydroxychloroquine

Brazil
blank

India disagrees with WHO over HCQ assessment – WHO trial dosages four times higher than Indian trials

Clinical Trials
blank

Australian hydroxychloroquine trials continue as Lancet is questioned over incorrect data

Australia
blank

Spain will continue to use hydroxychloroquine against the coronavirus despite the French ban and the doubts of the WHO

Hydroxychloroquine
blank

Sanford doctor: South Dakota’s hydroxychloroquine study different from others paused

Clinical Trials
blank

Study – Viral Dynamics Matter in COVID-19 Pneumonia: the success of early treatment with hydroxychloroquine and azithromycin in Lebanon. (94.7% Success rate)

Hydroxychloroquine
blank

EARLY DIAGNOSIS AND MANAGEMENT OF COVID-19 PATIENTS: A REAL-LIFE COHORT STUDY OF 3,737 PATIENTS, MARSEILLE, FRANCE (HCQ-AZ)

Clinical Trials
blank

Health Canada approves continuation of hydroxychloroquine clinical trials, deplores Lancet study that influenced WHO

Canada
blank

182 Professionals from 25 countries around the globe raise serious concerns with The Lancet’s anti HCQ report

Australia
blank

YALE: Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis (HCQ – AZ)

Clinical Trials
blank

The Campaign Against Hydroxychloroquine (HCQ)

Belgium
blank

TANG ET AL, BMJ: Favourable data for hydroxychloroquine removed between study’s draft and final print

France
blank

Nigeria: NAFDAC To Continue Hydroxychloroquine Trial Despite WHO’s Directive

Clinical Trials
blank

Brazilian scientists and academics write an open letter on the ‘science’ of the coronavirus pandemic

Brazil
blank

University of Edinburgh, Scotland, Centre for Clinical Brain Sciences finds Lancet report irrelevant

Hydroxychloroquine
blank

U.K. Health Care Workers Enroll in Trial Studying Hydroxychloroquine as Coronavirus Treatment

Hydroxychloroquine
blank

Australian researchers see virus design manipulation

Australia
blank

World renowned Dr leading one of the largest U.S. studies sees hydroxychloroquine promise

Hydroxychloroquine
blank

Study: Potential specific therapies in COVID-19 include hydroxychloroquine

Clinical Trials
blank

50 Science References Supporting Hydroxychloroquine: Microbiology Professor at Universidade de São Paulo, Paola Zanotto

Brazil
blank

Drug Battles – Politics, Profit & CoronaVirus

Hydroxychloroquine
blank

Moderate COVID 19: A First Report on the Pharmacological Outcomes from South Korea

Clinical Trials
blank

Adding Zinc to hydroxychloroquine and azithromycin improves odds: 44% less likely to die from COVID-19 (NYU Study of 900).

Hydroxychloroquine
blank

Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19

China
blank

Covid-19: Portugal without cases of “adverse reactions” to hydroxychloroquine

Hydroxychloroquine
blank

NIH Launches Clinical Trial to Study Hydroxychloroquine Efficacy in COVID-19

Clinical Trials
blank

Oxford Begins Study to Prevent Worsening of Mild Covid-19 Cases

Clinical Trials
blank

Tampa General Hospital workers in clinical trial using hydroxychloroquine as COVID-19 preventative

Clinical Trials
blank

Predicted success of prophylactic antiviral therapy to block or delay SARS-CoV-2 infection

France
blank

Early Hydroxychloroquine Is Associated with an Increase of Survival in COVID-19 Patients

Hydroxychloroquine
blank

Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients

Hydroxychloroquine
blank

Coronavirus: Professor critiques two studies, local AU tests of hydroxychloroquine to go ahead.

Australia
blank

Peer reviewed; 91.7% good outcomes with early treatment of COVID-19 patients using hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France

Clinical Trials
blank

Study of the safety and efficacy of chloroquine for the treatment of COVID-19

China
blank

Italian scientist says hydroxychloroquine could make people immune, believes she discovered main mechanism behind COVID-19

Hydroxychloroquine
blank

NYU: HCQ + azithromycin + zinc Vs. HCQ + azithromycin alone: outcomes in New York hospitalized COVID-19 patients

Clinical Trials
blank

China: Study re-affirms hydroxychloroquine useful in decreasing Covid deaths

China
blank

China study of 568 critically ill Covid-19 patients: Hydroxychloroquine treatment significantly associated with a decreased mortality, through attenuation of inflammatory cytokine storm.

China
blank

Uncover DC: Medical Misinformation, Part 1: Hydroxychloroquine

Hydroxychloroquine
blank

VA secretary defends use of hydroxychloroquine, clarifies an analysis led to substantial media misinformation

Clinical Trials
blank

Coronavirus Drug Exclusive: Meet a doctor behind an effective hydroxychloroquine treatment, and what’s next for its use

Hydroxychloroquine
blank

DRUG TRIAL 2,300 patients; physicians and surgeons (AAPS) say hydroxychloroquine drug DOES help 91% of coronavirus patients

Hydroxychloroquine
blank

Hydroxychloroquine application is associated with a decreased mortality in critically ill patients with COVID-19

China
blank

Iran: Covid-19 Study, a comprehensive investigation from exposure to treatment outcomes – HCQ a treatment option

Clinical Trials
blank

Response to Magagnoli, MedRxiv, 2020 Matthieu MILLION, Yanis ROUSSEL, Didier RAOULT

France
blank

Coronavirus: Major clinical trial set for virus treatments

Australia
blank

Hydroxychloroquine, the anti-malaria drug prevents Coronavirus: interview

Hydroxychloroquine
blank

FDA Allows Swiss Firm to Test Hydroxychloroquine

Clinical Trials
blank

Sermo Reports: One-Quarter of Global Physicians Agree That Healthcare Workers Should Take Hydroxychloroquine to Prevent COVID-19 Infections; Use of Hydroxychloroquine in Prophylaxis and Even in Undiagnosed Suspected Patient Cases is Seen

Global
blank

Greatest number of survivors from hydroxychloroquine – Healthcare analytics could provide a blueprint for coronavirus treatments

Hydroxychloroquine
blank

New Brazilian Study Shows Telemedicine & Hydroxychloroquine Reduce Need for Hospitalization

Brazil
blank

Can hydroxychloroquine prevent COVID-19? Study aims to find answers

Clinical Trials
blank

Sermo Reports Week 3 Results: Globally 17% Point Increase in COVID Treaters Who Have Used Hydroxychloroquine (33%-50%) and Azithromycin (41%-58%)

Global
blank

‘Going on offense’: South Dakota implements first statewide hydroxychloroquine trial in fight against coronavirus

Clinical Trials
blank

Gunma Univ. Hospital, Japan, Plans Clinical Research Covering Hydroxychloroquine

Clinical Trials
blank

Latest treatment results from the IHU pre-publication site on COVID-19. 1061 patients, 91% effective

France
blank

Les Echos – Didier Raoult unveils to Emmanuel Macron a study of 1061 patients, estimating 91% the effectiveness of his treatment against the coronavirus

France

International hydroxychloroquine news

02/07/2020
02/07/2020
29/06/2020
28/06/2020
25/06/2020
24/06/2020
23/06/2020
23/06/2020
23/06/2020
22/06/2020
22/06/2020
22/06/2020
20/06/2020
20/06/2020
19/06/2020
18/06/2020
17/06/2020
17/06/2020
17/06/2020
17/06/2020
16/06/2020
16/06/2020
16/06/2020
15/06/2020
15/06/2020
14/06/2020
13/06/2020
12/06/2020
12/06/2020
12/06/2020
11/06/2020
10/06/2020
10/06/2020
10/06/2020
08/06/2020
08/06/2020
08/06/2020
07/06/2020
04/06/2020
04/06/2020
03/06/2020
02/06/2020
02/06/2020
01/06/2020
01/06/2020
31/05/2020
31/05/2020
30/05/2020
30/05/2020
30/05/2020
29/05/2020
28/05/2020
28/05/2020
28/05/2020
28/05/2020
28/05/2020
28/05/2020
28/05/2020
28/05/2020
28/05/2020
27/05/2020
27/05/2020
27/05/2020
27/05/2020
26/05/2020
26/05/2020
25/05/2020
24/05/2020
24/05/2020
23/05/2020
23/05/2020
21/05/2020
21/05/2020
20/05/2020
20/05/2020
20/05/2020
18/05/2020
18/05/2020
18/05/2020
17/05/2020
17/05/2020
15/05/2020
15/05/2020
15/05/2020
15/05/2020
14/05/2020
13/05/2020
12/05/2020
12/05/2020
10/05/2020
08/05/2020
08/05/2020
08/05/2020
08/05/2020
08/05/2020
05/05/2020
04/05/2020
04/05/2020
04/05/2020
02/05/2020
blank

BREAKING: Hydroxychloroquine lowers Covid-19 death rate, new study confirms

Hydroxychloroquine
blank

Hydroxychloroquine significantly lowers COVID-19 death rate, Henry Ford Health study finds

Azithromycin
blank

The Gateway Pundit: STUNNING – Fauci’s Remdesivir Costs $9 Per Dose, Will Be Sold at $3,000 per Treatment — China Company Linked to Soros Will Also Mass Produce the Drug

News Article
blank

Multivitamin tablets, used with HCQ, flying off the shelves in Hyderabad

Hydroxychloroquine
blank

Controversies, hydroxychloroquine and investments: Prevent Senior accelerates in the crisis

Brazil
blank

Screening, hydroxychloroquine… Professor Raoult’s criticisms of the management of the health crisis

France
blank

The Coronavirus Is Man Made According to Luc Montagnier the Man Who Discovered HIV

France
blank

COVID-19: Nigerian study finds Chloroquine, Hydroxychloroquine effective as Prophylaxis

Chloroquine
blank

Health Impact News: Dr. Meryl Nass Discovers Hydroxychloroquine Experiments Were Designed to Kill COVID Patients – How Many Were Murdered?

Hydroxychloroquine
blank

Preliminary Injunction Sought to Release Hydroxychloroquine to the US Public – Studies Show Benefits

Hydroxychloroquine
blank

Moroccan Scientist: Morocco’s Hydroxychloroquine 82.5% Success Reveals European Failures

Africa
blank

A new study shows hydroxychloroquine would get out of hospital faster

France
blank

Bring on Britain’s corona clowns

Hydroxychloroquine
blank

Brazil: Doctor says Hydroxychloroquine should be initial treatment

Brazil
blank

India: HCQ beneficial as preventive drug: SMS doctors told ICMR

Hydroxychloroquine
blank

The Gold Opinion: The Politicization of HCQ

Hydroxychloroquine
blank

At 75% recovery rate, Rajasthan tops national average in curing COVID-19 patients

Hydroxychloroquine

Recovery is the British multi-arm, HCQ trial for COVID-19 that confuses doses and diseases.

France
blank

Researchers Overdosing COVID-19 Patients on Hydroxychloroquine, States Association of American Physicians & Surgeons (AAPS)

Clinical Trials
blank

Hydroxychloroquine is an anchor to prevent COVID-19 ICU Admissions In Malaysia: Expert

Hydroxychloroquine
blank

WHO “Solidarity” and UK “Recovery” Clinical Trials of Hydroxychloroquine Using Potentially Fatal Doses

Clinical Trials
blank

Due to significantly improved outcome, Henry Ford Health System continues hydroxychloroquine study

Hydroxychloroquine
blank

Only our agencies failed to grasp HCQ’s benefits, says U.S. President

Hydroxychloroquine
blank

Houston hospital has 99% survival rate using hydroxychloroquine to treat COVID-19 patients

Hydroxychloroquine
blank

Another anti hydroxychloroquine Study Turns out to Be a Joke

Chloroquine
blank

WHO and UK trials use potentially lethal hydroxychloroquine dose-according to WHO consultant

Canada
blank

Italia Oggi: Covid, none of mine are dead, by Alessandra Ricciardi

Hydroxychloroquine
blank

Study: Strategy – HCQ + AZ treats mild COVID-19 to reduce hospital admissions and complications.

Hydroxychloroquine
blank

Study: Pre exposure Hydroxychloroquine use reduces COVID19 risk in healthcare workers

Hydroxychloroquine
blank

Indonesia Claims Five Drug Combos, including HCQ, Reduce Novel Coronavirus

Hydroxychloroquine
blank

Production of Hydroxychloroquine more than requirement: India

Hydroxychloroquine
blank

Surgisphere: mass audit of studies linked to firm behind anti-hydroxychloroquine Lancet study scandal

Global
blank

Decreased mortality and hospital – Doxycycline and Hydroxychloroquine for High-Risk COVID-19 Patients: Case Series of 54 Patients in Long-Term Care

Hydroxychloroquine
blank

The Corruption of Science. The Hydroxychloroquine Lancet Study Scandal. Who Was Behind It? Anthony Fauci’s Intent To Block HCQ on Behalf of Big Pharma

Hydroxychloroquine
blank

Preventive HCQ measures saved city cops from getting infected.

Hydroxychloroquine
blank

Why Is Costa Rica’s hospitalization of patients with COVID-19 so low?

Costa Rica
blank

Back in favour, HCQ could spur India’s Covid-19 diplomacy

Hydroxychloroquine
blank

Egypt reveals results of hydroxychloroquine for people with coronavirus

Egypt
blank

WHO restarts Hydroxychloroquine trials globally after dubious study derailed progress – they’ve confirmed no risk of mortality

Clinical Trials
blank

WHO told governments to stop using HCQ based on suspect data from tiny US company. Trials now continue with new confidence.

Australia
blank

WHO resumes hydroxychloroquine study for Covid-19, after confirming no safety concerns from falsified Lancet study

Clinical Trials
blank

Hydroxychloroquine Misinformation Can Be Deadly: Let Patients Decide

Hydroxychloroquine
blank

Why That Observational Study of Hydroxychloroquine in The Lancet Seems Fishy

Global
blank

Honduras: Catracho, the Covid-19 treatment method the country is using to reduce deaths within an impoverished health system

Honduras
blank

80% dip in infection risk for Indian health staff on HCQ: Study

Hydroxychloroquine
blank

Peru will continue to use hydroxychloroquine to treat Covid-19 patients

Hydroxychloroquine
blank

Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19

France
blank

LancetGate: Surgisphere – is the company which provided the data to the study serious?

France
blank

Lancet HCQ, A Study Out of Thin Air

Global
blank

The big scam against hydroxychloroquine

Brazil
blank

India disagrees with WHO over HCQ assessment – WHO trial dosages four times higher than Indian trials

Clinical Trials
blank

Australian hydroxychloroquine trials continue as Lancet is questioned over incorrect data

Australia
blank

Spain will continue to use hydroxychloroquine against the coronavirus despite the French ban and the doubts of the WHO

Hydroxychloroquine
blank

Sanford doctor: South Dakota’s hydroxychloroquine study different from others paused

Clinical Trials
blank

Spain WILL NOT ban hydroxychloroquine, unlike other European nations spooked by reported side effects

Hydroxychloroquine
blank

Russia WILL NOT ban hydroxychloroquine for use in treating Covid-19

Hydroxychloroquine
blank

Costa Rica will continue to use hydroxychloroquine to treat COVID-19

Costa Rica
blank

Health Canada approves continuation of hydroxychloroquine clinical trials, deplores Lancet study that influenced WHO

Canada
blank

Brazil’s president says US President Trump is sending hydroxychloroquine tablets

Brazil
blank

The Campaign Against Hydroxychloroquine (HCQ)

Belgium
blank

Hydroxychloroquine: The Drug Costa Rica Uses Successfully To Fight Covid-19

Costa Rica
blank

Hydroxychloroquine and chloroquine: Morocco maintains its treatment, deplores Lancet’s data review

Chloroquine
blank

Salvadoran leader says he and most world leaders take hydroxychloroquine for coronavirus

El Salvador
blank

Despite WHO’s Warning, India Continues Use of Hydroxychloroquine as Prevention Measure

Hydroxychloroquine
blank

Algeria Backs Hydroxychloroquine Despite WHO Dropping Trials

Algeria
blank

Nigeria: NAFDAC To Continue Hydroxychloroquine Trial Despite WHO’s Directive

Clinical Trials
blank

Brazilian scientists and academics write an open letter on the ‘science’ of the coronavirus pandemic

Brazil
blank

University of Edinburgh, Scotland, Centre for Clinical Brain Sciences finds Lancet report irrelevant

Hydroxychloroquine
blank

Uganda also records good results treating COVID with hydroxychloroquine, chloroquine

Hydroxychloroquine
blank

Mexico to administer hydroxychloroquine to 20,000

Hydroxychloroquine
blank

Malaysia using hydroxychloroquine to treat Covid-19

Hydroxychloroquine
blank

U.K. Health Care Workers Enroll in Trial Studying Hydroxychloroquine as Coronavirus Treatment

Hydroxychloroquine
blank

Australian researchers see virus design manipulation

Australia
blank

Top Doctor at Oregon Prisons Requested Hydroxychloroquine to Treat Inmates With COVID-19

Hydroxychloroquine
blank

GOP lawmaker says his entire family is taking hydroxychloroquine

Hydroxychloroquine
blank

UK bulk buys hydroxychloroquine as potential Covid-19 treatment

Hydroxychloroquine
blank

Drug Battles – Politics, Profit & CoronaVirus

Hydroxychloroquine
blank

India sends hydroxychloroquine to Africa in war on coronavirus

Africa
blank

Moderate COVID 19: A First Report on the Pharmacological Outcomes from South Korea

Clinical Trials
blank

Adding Zinc to hydroxychloroquine and azithromycin improves odds: 44% less likely to die from COVID-19 (NYU Study of 900).

Hydroxychloroquine
blank

UW Medicine ramps up study of hydroxychloroquine and azithromycin for COVID-19 treatment

Clinical Trials
blank

Texan Pharmacy Board Backpedals on Restrictions for Hydroxychloroquine Prescriptions

Hydroxychloroquine
blank

War on hydroxychloroquine: Texas doctor describes ‘alarming’ barriers to treating patients

Hydroxychloroquine
blank

Covid-19: Portugal without cases of “adverse reactions” to hydroxychloroquine

Hydroxychloroquine
blank

NIH Launches Clinical Trial to Study Hydroxychloroquine Efficacy in COVID-19

Clinical Trials
blank

Kenya buys drug from India ahead of virus mass tests

Hydroxychloroquine
blank

Hydroxychloroquine Market Size Worth Around US$ 6 Bn by 2027

Global
blank

Oxford Begins Study to Prevent Worsening of Mild Covid-19 Cases

Clinical Trials
blank

Tampa General Hospital workers in clinical trial using hydroxychloroquine as COVID-19 preventative

Clinical Trials
blank

Hospital in Piauí heals people from covid-19 and empties ICUs with hydroxychloroquine

Brazil
blank

Hydroxychloroquine seized at Australian border

Australia
blank

Syrian Labs Churn Out Anti-Malarial Drug

Hydroxychloroquine
blank

Turkish company manufactures hydroxychloroquine drug

Hydroxychloroquine
blank

Coronavirus: Professor critiques two studies, local AU tests of hydroxychloroquine to go ahead.

Australia
blank

Turkish company develops hydroxychloroquine drug

Hydroxychloroquine
blank

Manufacturer to move hydroxychloroquine production to the UK to avoid shortage

Hydroxychloroquine
blank

Ghana: Eximbank to collaborate with Tobinco to produce Hydroxychloroquine, Azithromycin

Ghana
blank

Hydroxychloroquine and the Political Polarization of Science

Hydroxychloroquine
blank

‘India Providing 50 Lakh Hydroxychloroquine Tablets to Canada’: Envoy Ajay Bisaria

Canada
blank

NYU: HCQ + azithromycin + zinc Vs. HCQ + azithromycin alone: outcomes in New York hospitalized COVID-19 patients

Clinical Trials

Global announcments and official sources

01/07/2020
30/06/2020
29/06/2020
29/06/2020
26/06/2020
25/06/2020
22/06/2020
22/06/2020
22/06/2020
22/06/2020
19/06/2020
16/06/2020
12/06/2020
05/06/2020
04/06/2020
02/06/2020
02/06/2020
31/05/2020
31/05/2020
28/05/2020
28/05/2020
28/05/2020
28/05/2020
27/05/2020
26/05/2020
24/05/2020
22/05/2020
21/05/2020
19/05/2020
19/05/2020
18/05/2020
18/05/2020
15/05/2020
12/05/2020
09/05/2020
08/05/2020
08/05/2020
04/05/2020
02/05/2020
01/05/2020
30/04/2020
27/04/2020
24/04/2020
24/04/2020
23/04/2020
21/04/2020
18/04/2020
17/04/2020
17/04/2020
15/04/2020
14/04/2020
09/04/2020
08/04/2020
06/04/2020
02/04/2020
02/04/2020
02/04/2020
30/03/2020
27/03/2020
27/03/2020
24/03/2020
22/03/2020
22/03/2020
20/03/2020
12/03/2020
02/03/2020
17/12/2018
08/05/2018
23/11/2017
15/07/2014
11/09/2011
22/08/2005
07/05/1983
blank

HENRY FORD STUDY: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19

Azithromycin
blank

C19 Study: 48 studies (28 peer reviewed) showing “very positive” results using HCQ as pre & post exposure prophylaxis & early treatment.

Clinical Trials
blank

Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection.

Hydroxychloroquine
blank

Electrocardiographic safety of daily Hydroxychloroquine 400mg plus Azithromycin 250mg as an ambulatory treatment for COVID-19 patients in Cameroon.

Azithromycin
blank

National Cancer Instititute: List of Active Clinical Trials Using Hydroxychloroquine for Cancer

Clinical Trials
blank

Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/ azithromycin and other regimens in Marseille, France: A retrospective analysis

France
blank

Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of COVID-19 Spike pseudotype virus

China
blank

Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: a prospective open-label randomized controlled study

China
blank

Denmark: Chloroquine, but not hydroxychloroquine, prolongs the QT interval in a primary care population

Chloroquine
blank

Study|China- Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: a prospective open-label randomized controlled study

Chloroquine
blank

Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: a cohort study of 4,642 in-patients in France

Clinical Trials
blank

FDA ENABLES use of HCQ in a weird round about win – by revoking EUA. Says they never restricted it.

Hydroxychloroquine
blank

A short therapeutic regimen based on hydroxychloroquine plus azithromycin for the treatment of COVID-19 in patients with non-severe disease. A strategy associated with a reduction in hospital admissions and complications.

Azithromycin
blank

Lancet RETRACTS suspect research study of 96,000, which stated HCQ had no effect. Important win for science.

Global
blank

WHO restarts Hydroxychloroquine trials globally after dubious study derailed progress – they’ve confirmed no risk of mortality

Clinical Trials
blank

HCQ: The Lancet announces serious scientific questions about it’s own published study, which immediately halted WHO trials around the globe

Clinical Trials
blank

Association of American Physicians & Surgeons (AAPS) Sues the FDA to End Its Arbitrary Restrictions on Hydroxychloroquine

Hydroxychloroquine
blank

Health Co-operation between the Governments of Brazil and the United States

Brazil
blank

US Government delivers two million doses of hydroxychloroquine (HCQ) to the people of Brazil.

Brazil
blank

Study – Viral Dynamics Matter in COVID-19 Pneumonia: the success of early treatment with hydroxychloroquine and azithromycin in Lebanon. (94.7% Success rate)

Hydroxychloroquine
blank

EARLY DIAGNOSIS AND MANAGEMENT OF COVID-19 PATIENTS: A REAL-LIFE COHORT STUDY OF 3,737 PATIENTS, MARSEILLE, FRANCE (HCQ-AZ)

Clinical Trials
blank

182 Professionals from 25 countries around the globe raise serious concerns with The Lancet’s anti HCQ report

Australia
blank

YALE: Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis (HCQ – AZ)

Clinical Trials
blank

Most COVID-19 patients in Armenia show positive “dynamics” from hydroxychloroquine – ministry

Hydroxychloroquine
blank

TANG ET AL, BMJ: Favourable data for hydroxychloroquine removed between study’s draft and final print

France
blank

University of Edinburgh, Scotland, Centre for Clinical Brain Sciences finds Lancet report irrelevant

Hydroxychloroquine
blank

Revised advisory on the use of Hydroxychloroquine (HCQ) as prophylaxis for SARS-CoV-2 infection

Hydroxychloroquine
blank

Study: Potential specific therapies in COVID-19 include hydroxychloroquine

Clinical Trials
blank

VA Secretary Robert Wilkie: On Any Given Day, VA Uses 42,000 Doses Of Hydroxychloroquine

Hydroxychloroquine
blank

Trump takes hydroxychloroquine + zinc to prevent coronavirus infection as lots of evidence suggests it works

Hydroxychloroquine
blank

50 Science References Supporting Hydroxychloroquine: Microbiology Professor at Universidade de São Paulo, Paola Zanotto

Brazil
blank

White House letter: US freezes funding to WHO, pending 30 day review

Global
blank

Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19

China
blank

Predicted success of prophylactic antiviral therapy to block or delay SARS-CoV-2 infection

France
blank

Early Hydroxychloroquine Is Associated with an Increase of Survival in COVID-19 Patients

Hydroxychloroquine
blank

Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients

Hydroxychloroquine
blank

Peer reviewed; 91.7% good outcomes with early treatment of COVID-19 patients using hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France

Clinical Trials
blank

Study of the safety and efficacy of chloroquine for the treatment of COVID-19

China
blank

Yale’s COVID-19 inpatient official protocol: Hydroxychloroquine plus/minus tocilizumab

Hydroxychloroquine
blank

China study of 568 critically ill Covid-19 patients: Hydroxychloroquine treatment significantly associated with a decreased mortality, through attenuation of inflammatory cytokine storm.

China
blank

VA secretary defends use of hydroxychloroquine, clarifies an analysis led to substantial media misinformation

Clinical Trials